Current state of COVID-19 in children : 4 years on
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved..
Children have been disproportionately affected by the COVID-19 pandemic. Despite evidence of a very low risk of severe disease, children were subjected to extensive lockdown, restriction and mitigation measures, including school closures, to control the rapid spread of SARS-CoV-2 in most parts of the world. In this review we summarise the UK experience of COVID-19 in children four years into the largest and longest pandemic of this century. We address the risks of SARS-CoV-2 infection, immunity, transmission, severity and outcomes in children. We also assess the implementation, uptake, effectiveness and impact of COVID-19 vaccination, as well as the emergence, evolution and near disappearance of PIMS-TS (paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2) and current understanding of long COVID in children. This review consolidates current knowledge on childhood COVID-19 and emphasises the importance of continued research and the need for research-driven public health actions and policy decisions, especially in the context of new variants and future vaccines.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:88 |
---|---|
Enthalten in: |
The Journal of infection - 88(2024), 5 vom: 02. März, Seite 106134 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Powell, Annabel A [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 28.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.jinf.2024.106134 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369224574 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369224574 | ||
003 | DE-627 | ||
005 | 20240330001119.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240304s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jinf.2024.106134 |2 doi | |
028 | 5 | 2 | |a pubmed24n1355.xml |
035 | |a (DE-627)NLM369224574 | ||
035 | |a (NLM)38432584 | ||
035 | |a (PII)S0163-4453(24)00068-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Powell, Annabel A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Current state of COVID-19 in children |b 4 years on |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. | ||
520 | |a Children have been disproportionately affected by the COVID-19 pandemic. Despite evidence of a very low risk of severe disease, children were subjected to extensive lockdown, restriction and mitigation measures, including school closures, to control the rapid spread of SARS-CoV-2 in most parts of the world. In this review we summarise the UK experience of COVID-19 in children four years into the largest and longest pandemic of this century. We address the risks of SARS-CoV-2 infection, immunity, transmission, severity and outcomes in children. We also assess the implementation, uptake, effectiveness and impact of COVID-19 vaccination, as well as the emergence, evolution and near disappearance of PIMS-TS (paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2) and current understanding of long COVID in children. This review consolidates current knowledge on childhood COVID-19 and emphasises the importance of continued research and the need for research-driven public health actions and policy decisions, especially in the context of new variants and future vaccines | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Adolescents | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Children | |
650 | 4 | |a SARS-CoV-2 | |
700 | 1 | |a Dowell, Alexander C |e verfasserin |4 aut | |
700 | 1 | |a Moss, Paul |e verfasserin |4 aut | |
700 | 1 | |a Ladhani, Shamez N |e verfasserin |4 aut | |
700 | 0 | |a sKIDs Investigation Team |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 88(2024), 5 vom: 02. März, Seite 106134 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
773 | 1 | 8 | |g volume:88 |g year:2024 |g number:5 |g day:02 |g month:03 |g pages:106134 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2024.106134 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 88 |j 2024 |e 5 |b 02 |c 03 |h 106134 |